Inflammatory Response in the CNS: Friend or Foe?

Diack AB, Alibhai JD, Barron R, Bradford B, Piccardo P, Manson JC (2016) Insights into mechanisms of chronic neurodegeneration. Int J Mol Sci 17(1) Chen W-W, Zhang X, Huang W-J (2016) Role of neuroinflammation in neurodegenerative diseases (review). Mol Med Rep 13:3391–3396 Kohan R, Cismondi IA, Oller-Ramirez AM, Guelbert N, Anzolini TV, Alonso G et al (2011) Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr Pharm Biotechnol 12:867–883 DiSabato D, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem. doi:10.1111/jnc.13607 Waisman A, Liblau RS, Becher B (2015) Innate and adaptive immune responses in the CNS. Lancet Neurol 14:945–955 Headland SE, Norling LV (2015) The resolution of inflammation: principles and challenges. Semin Immunol 27:149–160 Całkosiński I, Dobrzyński M, Całkosińska M, Seweryn E, Bronowicka-Szydełko A et al (2009) Characterization of an inflammatory response. Post Hig Med Dosw (online) 63:395–408 Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9 Maskrey BH, Megson IL, Whitfield PD, Rossi AG (2011) Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 31:1001–1006 Shaw AC, Goldstein DR, Montgomery RR (2013) Age-dependent dysregulation of innate immunity. Nat Rev Immunol 13:875–887 Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F et al (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105 Salvioli S, Capri M, Valensin S, Tieri P, Monti D, Ottaviani E et al (2006) Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr Pharm Des 12:3161–3171 Batra A, Siegmund B (2012) The role of visceral fat. Dig Dis 30:70–74 Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL (2015) Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64:2289–2298 Skowrońska B, Fichna M, Fichna P (2005) The role of adipose tissue in the endocrine system. Endokrynol Otyłość Zaburz Przem Materii 1:21–29 Kim S-H, Chung J, Song S-W, Jung WS, Lee Y-A, Kim H-N (2016) Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study. Diabetol Metab Syndr 8:10 Kiliaan AJ, Arnoldussen IAC, Gustafson DR (2014) Adipokines: a link between obesity and dementia? Lancet Neurol 13:913–923 Li X, Song D, Leng SX (2015) Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 10:549–560 van Dijk G, van Heijningen S, Reijne AC, Nyakas C, van der Zee EA, Eisel ULM (2015) Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci 9:173 Kim B, Feldman EL (2015) Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 47:e149 Weltevrede M, Eilers R, de Melker HE, van Baarle D (2016) Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol 77:87–95 Bauer ME, Fuente MD la (2016) The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence. Mech Ageing Dev 7 Nasi M, Pinti M, De Biasi S, Gibellini L, Ferraro D, Mussini C et al (2014) Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV. Immunol Lett 162(1 Pt B):329–333 Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L et al (2008) The immune system in extreme longevity. Exp Gerontol 43:61–65 Johnson RW, Alvarez-Pasquin M-J, Bijl M, Franco E, Gaillat J, Clara JG et al (2015) Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines 3:109–120 Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405 Morales I, Guzmán-MartÃnez L, Cerda-Troncoso C, FarÃas GA, Maccioni RB (2014) Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112 Lim SL, Rodriguez-Ortiz CJ, Kitazawa M (2015) Infection, systemic inflammation, and Alzheimer’s disease. Microbes Infect 17:549–556 Schwartz M, Baruch K (2014) The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J 33:7–22 Russo MV, McGavern DB (2015) Immune surveillance of the CNS following infection and injury. Trends Immunol 36:637–650 Walsh JG, Muruve DA, Power C (2014) Inflammasomes in the CNS. Nat Rev Neurosci 15:84–97 Barichello T, Generoso JS, Goularte JA, Collodel A, Pitcher MR, Simões LR et al (2015) Does infection-induced immune activation contribute to dementia? Aging Dis 6:342–348 Khandelwal PJ, Herman AM, Moussa CE-H (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238:1–11 Tarr AJ, Liu X, Reed NS, Quan N (2014) Kinetic characteristics of euflammation: the induction of controlled inflammation without overt sickness behavior. Brain Behav Immun 42:96–108 Liu X, Nemeth DP, Tarr AJ, Belevych N, Syed ZW, Wang Y et al (2016) Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling. Brain Behav Immun 54:140–148 González H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201 Lun MP, Monuki ES, Lehtinen MK (2015) Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci 16:445–457 Schwartz M, Shechter R (2010) Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry 15:342–354 Schwartz M, Raposo C (2014) Protective autoimmunity: a unifying model for the immune network involved in CNS repair. Neurosci Rev J Bringing Neurobiol Neurol Psychiatry 20:343–358 Rezaie P, Male D (2002) Mesoglia & microglia—a historical review of the concept of mononuclear phagocytes within the central nervous system. J Hist Neurosci 11:325–374 Ginhoux F, Prinz M (2015) Origin of microglia: current concepts and past controversies. Cold Spring Harb Perspect Biol 7:a020537 Hristovska I, Pascual O (2015) Deciphering resting microglial morphology and process motility from a synaptic prospect. Front Integr Neurosci 9:73 Correale J (2014) The role of microglial activation in disease progression. Mult Scler Houndmills Basingstoke Engl 20:1288–1295 Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV (2013) Microglia activation as a biomarker for traumatic brain injury. Front Neurol 4:30 Ginhoux F, Lim S, Hoeffel G, Low D, Huber T (2013) Origin and differentiation of microglia. Front Cell Neurosci 7:45 Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367–402 Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B (2015) Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol 36:605–613 Neumann H, Kotter MR, Franklin RJM (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain J Neurol 132:288–295 Bahrini I, Song J, Diez D, Hanayama R (2015) Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep 5:7989 Bátiz LF, Castro MA, Burgos PV, Velásquez ZD, Muñoz RI, Lafourcade CA et al (2015) Exosomes as novel regulators of adult neurogenic niches. Front Cell Neurosci 9:501 Pegtel DM, Peferoen L, Amor S (2014) Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philos Trans R Soc Lond B Biol Sci 369(1652) Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS et al (2013) Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604 Bellingham SA, Guo BB, Coleman BM, Hill AF (2012) Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol 3:124 Turola E, Furlan R, Bianco F, Matteoli M, Verderio C (2012) Microglial microvesicle secretion and intercellular signaling. Front Physiol 3:149 Properzi F, Logozzi M, Fais S (2013) Exosomes: the future of biomarkers in medicine. Biomark Med 7:769–778 Wang X, Zhao L, Zhang J, Fariss RN, Ma W, Kretschmer F et al (2016) Requirement for microglia for the maintenance of synaptic function and integrity in the mature retina. J Neurosci 36:2827–2842 Gertig U, Hanisch U-K (2014) Microglial diversity by responses and responders. Front Cell Neurosci 8:101 Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease—a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2:a006346 Streit WJ, Xue Q-S (2009) Life and death of microglia. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 4:371–379 Luo X-G, Chen S-D (2012) The changing phenotype of microglia from homeostasis to disease. Transl Neurodegener 1:9 von Bernhardi R, Eugenín-von Bernhardi L, Eugenín J (2015) Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci 7:124 Lynch MA (2014) The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer’s disease. Immunology 141:292–301 Colton CA (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 4:399–418 Walker DG, Lue L-F (2015) Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther 7:56 Cappellano G, Carecchio M, Fleetwood T, Magistrelli L, Cantello R, Dianzani U et al (2013) Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis 2:89–107 Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463–477 Ferrini F, De Koninck Y (2013) Microglia control neuronal network excitability via BDNF signalling. Neural Plast 2013:429815 Alboni S, Maggi L (2015) Editorial: cytokines as players of neuronal plasticity and sensitivity to environment in healthy and pathological brain. Front Cell Neurosci 9:508 Sajja VSSS, Hlavac N, VandeVord PJ (2016) Role of glia in memory deficits following traumatic brain injury: biomarkers of glia dysfunction. Front Integr Neurosci 10:7 Camara ML, Corrigan F, Jaehne EJ, Jawahar MC, Anscomb H, Koerner H et al (2013) TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice. Psychoneuroendocrinology 38:3102–3114 Steinmetz CC, Turrigiano GG (2010) Tumor necrosis factor-α signaling maintains the ability of cortical synapses to express synaptic scaling. J Neurosci 30:14685–14690 Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurother J Am Soc Exp Neurother 7:354–365 Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15:300–312 Block ML, Hong J-S (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127–1132 Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G (2016) Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system. CNS Neurol Disord Drug Targets 15:329–336 Fischer R, Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxidative Med Cell Longev 2015:610813 Sochocka M, Koutsouraki ES, Gasiorowski K, Leszek J (2013) Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy. CNS Neurol Disord Drug Targets 12:870–881 Wu Z, Yu J, Zhu A, Nakanishi H (2016) Nutrients, microglia aging, and brain aging. Oxidative Med Cell Longev 2016:7498528 Varnum MM, Ikezu T (2012) The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain. Arch Immunol Ther Exp 60:251–266 Yu Z, Sun D, Feng J, Tan W, Fang X, Zhao M et al (2015) MSX3 switches microglia polarization and protects from inflammation-induced demyelination. J Neurosci 35:6350–6365 Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98 Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM et al (2012) The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One 7:e45250 McGeer PL, McGeer EG (2015) Targeting microglia for the treatment of Alzheimer’s disease. Expert Opin Ther Targets 19:497–506 Latta CH, Brothers HM, Wilcock DM (2015) Neuroinflammation in Alzheimer’s disease; a source of heterogeneity and target for personalized therapy. Neuroscience 302:103–111 Moore CS, Rao VTS, Durafourt BA, Bedell BJ, Ludwin SK, Bar-Or A et al (2013) miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization. Ann Neurol 74:709–720 Hamzei Taj S, Kho W, Riou A, Wiedermann D, Hoehn M (2016) MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials 91:151–165 Ponomarev ED, Veremeyko T, Weiner HL (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61:91–103 Magistretti PJ, Ransom BR (2002) Astrocytes. Neuropsychopharmacology: the fifth generation of progress. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds). Williams and Wilkins, Philadelphia, Lippincott, pp 133–145 Steardo L, Bronzuoli MR, Iacomino A, Esposito G, Steardo L, Scuderi C (2015) Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes. Front Neurosci 9:259 Messing A, Brenner M (2003) GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43:87–90 Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T et al (2007) Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia 55:617–631 Mohn TC, Koob AO (2015) Adult astrogenesis and the etiology of cortical neurodegeneration. J Exp Neurosci 9(Suppl 2):25–34 Fuller S, Steele M, Münch G (2010) Activated astroglia during chronic inflammation in Alzheimer’s disease—do they neglect their neurosupportive roles? Mutat Res 690:40–49 Zhao J, O’Connor T, Vassar R (2011) The contribution of activated astrocytes to Aβ production: implications for Alzheimer’s disease pathogenesis. J Neuroinflammation 8:150 Efremova L, Chovancova P, Adam M, Gutbier S, Schildknecht S, Leist M (2016) Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation. Arch Toxicol Apr 6 Villegas-Llerena C, Phillips A, Garcia-Reitboeck P, Hardy J, Pocock JM (2016) Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease. Curr Opin Neurobiol 36:74–81 Yoon S, Kim Y (2015) The role of immunity and neuroinflammation in genetic predisposition. Aims Genet 2:230–249 Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A (2008) Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer’s pathology. J Cell Mol Med 12:2255–2262 de Vasconcelos NM, Van Opdenbosch N, Lamkanfi M (2016) Inflammasomes as polyvalent cell death platforms. Cell Mol Life Sci CMLS 73:2335–2347 Liu L, Chan C (2014) The role of inflammasome in Alzheimer’s disease. Ageing Res Rev 15:6–15 Tan M-S, Yu J-T, Jiang T, Zhu X-C, Tan L (2013) The NLRP3 inflammasome in Alzheimer’s disease. Mol Neurobiol 48:875–882 Heneka MT, Golenbock DT, Latz E (2015) Innate immunity in Alzheimer’s disease. Nat Immunol 16:229–236 Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE et al (2001) In-vivo measurement of activated microglia in dementia. Lancet Lond Engl 358:461–467 Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE et al (2008) Microglia, amyloid, and cognition in Alzheimer’s disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32:412–419 Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R et al (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72:56–62 Crack PJ, Bray PJ (2007) Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 85:476–480 Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11:373–384 Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M et al (2009) Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid-beta neurotoxicity in in vitro and in vivo models of Alzheimer’s disease. Am J Pathol 175:2121–2132 Fassbender K, Walter S, Kühl S, Landmann R, Ishii K, Bertsch T et al (2004) The LPS receptor (CD14) links innate immunity with Alzheimer’s disease. FASEB J Off Publ Fed Am Soc Exp Biol 18:203–205 Kielian T (2006) Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83:711–730 Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC et al (2009) Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer’s disease-related pathology. J Neurosci 29:1846–1854 Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B et al (2012) TLR2 is a primary receptor for Alzheimer’s amyloid β peptide to trigger neuroinflammatory activation. J Immunol 188:1098–1107 Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8:49–62 Vigneron A, Vousden KH (2010) p53, ROS and senescence in the control of aging. Aging 2:471–474 Lucin KM, O’Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ et al (2013) Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease. Neuron 79:873–886 Jaeger PA, Pickford F, Sun C-H, Lucin KM, Masliah E, Wyss-Coray T (2010) Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One 5:e11102 Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H et al (2013) Impaired autophagy and APP processing in Alzheimer’s disease: the potential role of Beclin 1 interactome. Prog Neurobiol 106–107:33–54 Painter MM, Atagi Y, Liu C-C, Rademakers R, Xu H, Fryer JD et al (2015) TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener 10:43 Boutajangout A, Wisniewski T (2013) The innate immune system in Alzheimer’s disease. Int J Cell Biol 2013:576383 Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML et al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160:1061–1071 Jiang T, Zhang Y-D, Chen Q, Gao Q, Zhu X-C, Zhou J-S et al (2016) TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Neuropharmacology 105:196–206 Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard A-C, Rollin-Sillaire A et al (2013) TREM2 R47H variant as a risk factor for early-onset Alzheimer’s disease. J Alzheimers Dis JAD 35:45–49 Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J et al (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368:107–116 Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM et al (2015) The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement J Alzheimers Assoc 11:1407–1416 Rivest S (2015) TREM2 enables amyloid β clearance by microglia. Cell Res 25:535–536 Ulrich JD, Holtzman DM (2016) TREM2 function in Alzheimer’s disease and neurodegeneration. ACS Chem Neurosci 7:420–427 Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17:201–207 Hamelin L, Lagarde J, Dorothée G, Leroy C, Labit M, Comley RA et al (2016) Early and protective microglial activation in Alzheimer’s disease: a prospective study using 18F-DPA-714 PET imaging. Brain J Neurol 139:1252–1264 Refolo V, Stefanowa N (2015) Microglia activation as a therapeutic target in multiple system atrophy: the timing, the good and the bad. Macrophage 2:e1065 Griffin WST, Mrak RE (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease. J Leukoc Biol 72:233–238 McNaull BBA, Todd S, McGuinness B, Passmore AP (2010) Inflammation and anti-inflammatory strategies for Alzheimer’s disease—a mini-review. Gerontology 56:3–14 Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer’s disease, role of cytokines. ScientificWorldJournal 2012:756357 McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33:355–366 Delaby C, Gabelle A, Blum D, Schraen-Maschke S, Moulinier A, Boulanghien J et al (2015) Central nervous system and peripheral inflammatory processes in Alzheimer’s disease: biomarker profiling approach. Front Neurol 6:181 Zambrano A, Otth C, Maccioni RB, Concha II (2010) IL-3 controls tau modifications and protects cortical neurons from neurodegeneration. Curr Alzheimer Res 7:615–624 Zambrano A, Otth C, Mujica L, Concha II, Maccioni RB (2007) Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci 8:82 Natarajan C, Sriram S, Muthian G, Bright JJ (2004) Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia 45:188–196 Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10–20 Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604 Latta CH, Sudduth TL, Weekman EM, Brothers HM, Abner EL, Popa GJ et al (2015) Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice. J Neuroinflammation 12:41 Liu C, Cui G, Zhu M, Kang X, Guo H (2014) Neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol 7:8342–8355 Guillot-Sestier M-V, Doty KR, Gate D, Rodriguez J, Leung BP, Rezai-Zadeh K et al (2015) Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85:534–548 Aloisi F, Penna G, Cerase J, Menéndez Iglesias B, Adorini L (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol Baltim Md 1950 159:1604–1612 Vom Berg J, Prokop S, Miller KR, Obst J, Kälin RE, Lopategui-Cabezas I et al (2012) Inhibition of IL-12/IL-23 signaling reduces Alzheimer’s disease-like pathology and cognitive decline. Nat Med 18:1812–1819 Bishnoi RJ, Palmer RF, Royall DR (2015) Serum interleukin (IL)-15 as a biomarker of Alzheimer’s disease. PLoS One 10:e0117282 Rentzos M, Rombos A (2012) The role of IL-15 in central nervous system disorders. Acta Neurol Scand 125:77–82 Sutinen EM, Pirttilä T, Anderson G, Salminen A, Ojala JO (2012) Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells. J Neuroinflammation 9:199 Salani F, Ciaramella A, Bizzoni F, Assogna F, Caltagirone C, Spalletta G et al (2013) Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer’s disease. Cytokine 61:360–363 Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M et al (2011) Production and functions of IL-33 in the central nervous system. Brain Res 1385:8–17 Gadani SP, Walsh JT, Lukens JR, Kipnis J (2015) Dealing with danger in the CNS: the response of the immune system to injury. Neuron 87:47–62 Zheng C, Zhou X-W, Wang J-Z (2016) The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ. Transl Neurodegener 5:7 Sriram K, O’Callaghan JP (2007) Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 2:140–153 Rocha NP, Teixeira AL, Coelho FM, Caramelli P, Guimarães HC, Barbosa IG et al (2012) Peripheral blood mono-nuclear cells derived from Alzheimer’s disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide. Mol Cell Neurosci 49:77–84 Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer’s disease: molecular mechanisms. Int J Dev Neurosci Off J Int Soc Dev Neurosci 24:167–176 Hsieh H-L, Yang C-M (2013) Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int 2013:484613 Fischer R, Maier O, Siegemund M, Wajant H, Scheurich P, Pfizenmaier K (2011) A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death. PLoS One 6:e27621 Chiarini A, Dal Pra I, Whitfield JF, Armato U (2006) The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines. Ital J Anat Embryol Arch Ital Anat Ed Embriologia 111:221–246 Kempuraj D, Khan MM, Thangavel R, Xiong Z, Yang E, Zaheer A (2013) Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 8:643–650 Ryu JK, Cho T, Choi HB, Jantaratnotai N, McLarnon JG (2015) Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease. J Neuroinflammation 12:144 Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA (2003) p53-dependent cell death signaling in neurons. Neurochem Res 28:15–27 Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331:761–777 Chang JR, Ghafouri M, Mukerjee R, Bagashev A, Chabrashvili T, Sawaya BE (2012) Role of p53 in neurodegenerative diseases. Neurodegener Dis 9:68–80 Lanni C, Uberti D, Racchi M, Govoni S, Memo M (2007) Unfolded p53: a potential biomarker for Alzheimer’s disease. J Alzheimers Dis JAD 12:93–99 Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297 Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12:613–626 Eun B, Cho B, Moon Y, Kim SY, Kim K, Kim H et al (2010) Induction of neuronal apoptosis by expression of Hes6 via p53-dependent pathway. Brain Res 1313:1–8 Hooper C, Meimaridou E, Tavassoli M, Melino G, Lovestone S, Killick R (2007) p53 is upregulated in Alzheimer’s disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett 418:34–37 Maddocks ODK, Vousden KH (2011) Metabolic regulation by p53. J Mol Med Berl Ger 89:237–245 Vousden KH (2010) Alternative fuel—another role for p53 in the regulation of metabolism. Proc Natl Acad Sci U S A 107:7117–7118 Cai D (2013) Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab TEM 24:40–47 Buizza L, Prandelli C, Bonini SA, Delbarba A, Cenini G, Lanni C et al (2013) Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression. Cell Death Dis 4:e484 Stanga S, Lanni C, Govoni S, Uberti D, D’Orazi G, Racchi M (2010) Unfolded p53 in the pathogenesis of Alzheimer’s disease: is HIPK2 the link? Aging 2:545–554 Bendotti C, Baldessari S, Pende M, Southgate T, Guglielmetti F, Samanin R (1997) Relationship between GAP-43 expression in the dentate gyrus and synaptic reorganization of hippocampal mossy fibres in rats treated with kainic acid. Eur J Neurosci 9:93–101 Ambros V, Chen X (2007) The regulation of genes and genomes by small RNAs. Dev Camb Engl 134:1635–1641 Leung AKL, Sharp PA (2010) MicroRNA functions in stress responses. Mol Cell 40:205–215 Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172–1187 Holcik M, Sonenberg N (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318–327 Vojta A, Zoldoš V (2013) Adaptation or malignant transformation: the two faces of epigenetically mediated response to stress. Biomed Res Int 2013:954060 Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM (2012) p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149:1536–1548 Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K (2009) Modulation of microRNA processing by p53. Nature 460:529–533 Suzuki HI, Miyazono K (2010) Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. J Mol Med Berl Ger 88:1085–1094